M. Borms

Fulvestrant (Faslodex™) in advanced breast cancer: clinical experience from a Belgian cooperative study

P. Neven, R. Paridaens, M. Christiaens, 2008, Breast Cancer Research and Treatment.

Serum tumor markers and PET/CT imaging for tumor recurrence detection

A. Maes, V. Cocquyt, C. Wiele, 2013, Annals of Nuclear Medicine.

A randomised wait-list controlled trial to evaluate Emotional Freedom Techniques for self-reported cancer-related cognitive impairment in cancer survivors (EMOTICON)

P. Schofield, M. Lycke, Tessa Lefebvre, 2021, EClinicalMedicine.

Validation of the Freund Clock Drawing Test as a screening tool to detect cognitive dysfunction in elderly cancer patients undergoing comprehensive geriatric assessment

H. Wildiers, M. Lycke, L. Pottel, 2014, Psycho-Oncology.

Comparison of L-758,298, a prodrug for the selective neurokinin-1 antagonist, L-754,030, with ondansetron for the prevention of cisplatin-induced emesis.

M. Decramer, J. Schellens, J. Schellens, 2001, European journal of cancer.

CA 15.3 measurements for separating FDG PET/CT positive from negative findings in breast carcinoma recurrence

A. Maes, C. Van de Wiele, H. Pottel, 2014, Nuklearmedizin.

PSMA expression on neovasculature of solid tumors.

A. Maes, C. Van de Wiele, P. Debruyne, 2020, Histology and histopathology.

Phosphorylated HER-2 tyrosine kinase and Her-2/neu gene amplification as predictive factors of response to trastuzumab in patients with HER-2 overexpressing metastatic breast cancer (MBC).

C. Sotiriou, D. Larsimont, M. Piccart, 2007, European journal of cancer.

Vorozole-racemate (R 76713): A specific non-steroidal aromatase inhibitor. Pilot study advanced postmenopausal breast cancer

C. Langenaeken, R. Coster, J. Bruynseels, 1993 .

Reproducibility of FDG PET based metabolic tumor volume measurements and of their FDG distribution within.

A. Maes, C. Van de Wiele, V. Cocquyt, 2015, The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of....

Validation of the Freund Clock Drawing Test as a screening tool to detect cognitive dysfunction in elderly cancer patients undergoing comprehensive geriatric assessment

H. Wildiers, M. Lycke, L. Pottel, 2014, Psycho-oncology.